Clinical Trial Update: Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy [NA]

View source ↗

Summary

This clinical trial explores shared mechanisms contributing to non-alcoholic fatty liver disease and psoriatic arthritis severity and evaluates guselkumab thera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Psoriatic Arthritis

Drugs mentioned

• Guselkumab (guselkumab)

Snippet

Sponsor: University of California, San Diego | Conditions: Psoriatic Arthritis | NA | Status: RECRUITING